Home/ Supplements/ Melatonin/ Sleep Tight Liquid Melatonin 3 mg Berry ...

Sleep Tight Liquid Melatonin 3 mg Berry Flavour!

product on market Liquid Nature's Harmony Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

This product contains synthetic melatonin, which is supported by strong evidence for reducing sleep onset latency. Research indicates it helps regulate circadian rhythms to improve sleep quality. However, the overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Sleep Tight Liquid Melatonin 3 mg Berry Flavour!
Open Full PDF View on NIH DSLD →
Details

Label Data

1 mL
Serving Size
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 3.0mg (984 products) 240 studies (A:2, B:109)

Other Ingredients

filtered Water Fructose natural berry flavour Malic Acid Sodium Benzoate Potassium Sorbate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Recommended Use: Helps increase total sleep time aspect of sleep quality in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag. Helps to relieve the daytime fatigue associated with jet lag. Helps reduce the time it takes to fall asleep in people with delayed sleep phase syndrome. Helps reset the body's sleep-wake cycle aspect of circadian rhythm. Recommended Dose (Adults): Take 1 dropper (1 mL) a day at bedtime only. For use beyond four weeks, consult a health care practitioner.

Shake prior to use.

Warnings & Precautions

Risk Information: Do not use if you are pregnant, breastfeeding or taking immunosuppressive drugs. Consult a health care practitioner prior to use if you have a hormonal disorder, diabetes, liver or kidney disease, cerebral palsy, seizure disorders, migraine, depression and/or hypertension or if you are taking blood pressure or sedative/hypnotic medications.

If symptoms persist continuously for more than four weeks, consult your health care practitioner.

Do not drive or use machinery for five hours after taking melatonin.

Keep out of reach of children.

DO NOT USE IF SECURITY SEAL IS BROKEN.

Formulation Notes

This product does not contain dairy, egg, gluten, shellfish, soy, sulfites, animal derivatives, or artificial colours or flavours.

Additional Information

Refrigerate after opening or use within 60 days.

Protect from heat, light and moisture.

400185.01-02

UPC CODE TO BE: 0 63047 00185 0

Helps Increase Total Sleep Time and Sleep Quality

SunOpta A healthy products company

A Proud Canadian Company

Metadata

Product Details

DSLD Entry Date2013-05-24
Product TypeNon-Nutrient/Non-Botanical
FormLiquid
DSLD ID21928
Data Updated2026-04-11
Research

Research Evidence

291
Research Sources
55
Avg Quality
129
Meta Analysis
93
Systematic Review
51
Rct
11
Clinical Trial
2
Other
2
Regulatory Source
1
Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022 PubMed DOI
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022 PubMed DOI
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023 PubMed DOI
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Melatonin →
Compare

Similar Products

View all Melatonin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.